Our team found that significantly elevated levels of pre‐rRNA were observed in clinical AML patients with PHF6 mutation and loss of PHF6 may promote rDNA transcription to mediate chemotherapy resistance by regulating histone epigenetic modification of rDNA loci (data not shown). Here, PHF6 is linked to acute myeloid leukemia.